Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lisa Allander"'
Autor:
Anni-Maria Örmälä-Tiznado, Lisa Allander, Makaoui Maatallah, Muhammad Humaun Kabir, Sylvain Brisse, Linus Sandegren, Sheetal Patpatia, Maarten Coorens, Christian G. Giske
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 2 (2024)
ABSTRACTExtensively drug-resistant (XDR) Klebsiella pneumoniae inflict a notable burden on healthcare worldwide. Of specific concern are strains producing carbapenem-hydrolyzing enzymes, as the therapeutic options for these strains are still very lim
Externí odkaz:
https://doaj.org/article/dbea8406f1f9474db7ef2690e08e6cec
Autor:
Katarzyna Palica, Manuela Vorácová, Susann Skagseth, Anna Andersson Rasmussen, Lisa Allander, Madlen Hubert, Linus Sandegren, Hanna-Kirstirep Schrøder Leiros, Hanna Andersson, Máté Erdélyi
Publikováno v:
ACS Omega, Vol 7, Iss 5, Pp 4550-4562 (2022)
Externí odkaz:
https://doaj.org/article/08ea26c51b5b4205a2850ef819bf1bc7
Publikováno v:
Antibiotics, Vol 11, Iss 11, p 1646 (2022)
Double-carbapenem combinations have shown synergistic potential against carbapenemase-producing Enterobacterales, but data remain inconclusive. This study evaluated the activity of double-carbapenem combinations against 51 clinical KPC-2-, OXA-48-, N
Externí odkaz:
https://doaj.org/article/b787c6461766491e82e1f2169ee6b7cc
Autor:
Elias Dahdouh, Lisa Allander, Linda Falgenhauer, Bogdan I. Iorga, Stefano Lorenzetti, Íñigo Marcos-Alcalde, Nathaniel I. Martin, Luis Martínez-Martínez, Jesús Mingorance, Thierry Naas, Joseph E. Rubin, Francesca Spyrakis, Thomas Tängdén, Paulino Gómez-Puertas
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 17, p 9746 (2022)
The EPIC consortium brings together experts from a wide range of fields that include clinical, molecular and basic microbiology, infectious diseases, computational biology and chemistry, drug discovery and design, bioinformatics, biochemistry, biophy
Externí odkaz:
https://doaj.org/article/5a1cf8dde3184d1bada38a6ebc146bfa
Autor:
Elias Dahdouh, Lisa Allander, Linda Falgenhauer, Bogdan I. Iorga, Stefano Lorenzetti, Íñigo Marcos-Alcalde, Nathaniel I. Martin, Luis Martínez-Martínez, Jesús Mingorance, Thierry Naas, Joseph E. Rubin, Francesca Spyrakis, Thomas Tängdén, Paulino Gómez-Puertas
Publikováno v:
International Journal of Molecular Sciences, 23(17):9746. MDPI AG
The EPIC consortium brings together experts from a wide range of fields that include clinical, molecular and basic microbiology, infectious diseases, computational biology and chemistry, drug discovery and design, bioinformatics, biochemistry, biophy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23a9bc342f51f20d60e52c00a58d6c2c
https://doi.org/10.3390/ijms23179746
https://doi.org/10.3390/ijms23179746
Publikováno v:
Antimicrob Agents Chemother
β-Lactam antibiotics are the first choice for the treatment of most bacterial infections. However, the increased prevalence of β-lactamases, in particular extended-spectrum β-lactamases, in pathogenic bacteria has severely limited the possibility
Autor:
Anna‐Lisa Allander, J. Tillgren
Publikováno v:
Acta Medica Scandinavica. 71:147-164